Authors: van Tienhoven, EAE ten Brink, CTB van Bergen, J Koning, F van Eden, W Broeren, CPM

Citation: Eae. Van Tienhoven et al., Induction of antigen specific CD4+T cell responses by invariant chain based DNA vaccines, VACCINE, 19(11-12), 2001, pp. 1515-1519

Authors: van Bergen, J Kooy, Y Koning, F

Citation: J. Van Bergen et al., CD4-independent T cells impair TCR triggering of CD4-dependent T cells: a putative mechanism for T cell affinity maturation, EUR J IMMUN, 31(2), 2001, pp. 646-652

Authors: van Hall, T van Bergen, J van Veelen, PA Kraakman, M Henkamp, LC Koning, F Melief, CJM Ossendorp, F Offringa, R

Citation: T. Van Hall et al., Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin, J IMMUNOL, 165(2), 2000, pp. 869-877

Authors: van Bergen, J Camps, M Offringa, R Melief, CJM Ossendorp, F Koning, F

Citation: J. Van Bergen et al., Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide, CANCER RES, 60(22), 2000, pp. 6427-6433

Authors: van Bergen, J Ossendorp, F Jordens, R Mommaas, AM Drijfhout, JW Koning, F

Citation: J. Van Bergen et al., Get into the groove! Targeting antigens to MHC class II, IMMUNOL REV, 172, 1999, pp. 87-96

Authors: ten Bosch, GJA Kessler, JH Joosten, AM Bres-Vloemans, AA Geluk, A Godthelp, BC van Bergen, J Melief, CJM Leeksma, OC

Citation: Gja. Ten Bosch et al., A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct, BLOOD, 94(3), 1999, pp. 1038-1045